News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Mariano Provencio: Perioperative chemotherapy and nivolumab in NSCLC
Oct 18, 2024, 19:52

Mariano Provencio: Perioperative chemotherapy and nivolumab in NSCLC

Mariano Provencio, Medical Oncology Chair at University Hospital Puerta de Hierro, shared on X:

”With NADIM at Spanish Lung Cancer Group (Grupo Español de Cáncer de Pulmón), we were disruptive. We had to overcome skepticism to break the standard.

Today, 5 years later, The Lancet Oncology confirms the robustness of our strategy. 69% alive at 5Y, without severe toxicities. Congratulations.”

Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial

Authors: Mariano Provencio, Ernest Nadal, Amelia Insa, Rosario García Campelo, Joaquín Casal, Manuel Dómine, Bartomeu Massuti, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martínez-Martí, Javier de Castro, David Gómez de Antonio, Iván Macia, Santiago Figueroa, Luís Fernández Vago, Virginia Calvo, Ramón Palmero, Belén Sierra-Rodero, Cristina Martínez-Toledo, Marta Molina-Alejandre, Roberto Serna-Blasco, Atocha Romero, Alberto Cruz-Bermúdez.

Mariano Provencio: Perioperative chemotherapy and nivolumab in NSCLC

Alberto Cruz-Bermúdez. Alex Martínez-Martí Amelia Insa Atocha Romero Bartomeu Massuti Belén Sierra-Rodero cancer Cristina Martínez-Toledo David Gómez de Antonio Delvys Rodriguez Abreu Ernest Nadal Grupo Español de Cáncer de Pulmón Iván Macia Javier de Castro Joaquín Casal Luís Fernández Vago Lung cancer M. Provencio Manuel Dómine Margarita Majem Mariano Provencio Marta Molina-Alejandre nivolumab OncoDaily Oncology Perioperative Chemotherapy Ramón Palmero Roberto Serna-Blasco Rosario García-Campelo Santiago Figueroa The Lancet Oncology Virginia Calvo
Special Coverage
Insight
Dec 19, 2024, 07:27
Geoffrey Shapiro Honored with MSCO Distinguished Researcher Award
Drugs
Dec 19, 2024, 07:24
U.S. FDA Grants Breakthrough Therapy Designation to Trodelvy®
Insight
Dec 19, 2024, 07:21
Post ASH24: The Most Important MPN Studies - IACH
Blog
Dec 19, 2024, 07:20
Kimryn Rathmell: Finding Hope - Ending Cancer as We Know It
Insight
Dec 19, 2024, 07:17
Last days for early bird registrations for COPS2025 - INDEPSO
Insight
Dec 19, 2024, 07:16
Major Changes in NCI ACE Award: Removal of Citizenship Requirements and Eligibility Limitations
Blog
Dec 19, 2024, 07:12
European Cancer Organisation - Getting There on Time: Time to Treatment in Cancer in Europe
Blog
Dec 19, 2024, 06:53
Martin Guscott: Detection of somatic structural variants of circulating tumor DNA in children with solid tumors
Blog
Dec 19, 2024, 02:54
Bladder-Sparing Strategies for MIBC: Insights from Professor Ming Cao at ESMO Asia2024
Blog
Dec 19, 2024, 02:52
Vicki Kennedy: The critical importance of psychosocial oncology standards
Blog
Dec 19, 2024, 02:47
Liver cancer treatment through radioembolization - IMAGIO
Blog
Dec 19, 2024, 02:43
Paolo Tarantino: The highly awaited Breast Cancer trials with positive results